BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8902594)

  • 1. Expression of two different cholecystokinin receptors in Xenopus oocytes injected with mRNA from rabbit pancreas and rat hippocampus.
    Shigeri Y; Shinohara S; Murata S; Fujimoto M; Kawasaki K
    Jpn J Pharmacol; 1996 Sep; 72(1):9-15. PubMed ID: 8902594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The excitatory effect of cholecystokinin on rat neostriatal neurons: ionic and molecular mechanisms.
    Wu T; Wang HL
    Eur J Pharmacol; 1996 Jun; 307(2):125-32. PubMed ID: 8832213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
    Mosher JT; Johnson MF; Birkemo LS; Ervin GN
    Peptides; 1996; 17(3):483-8. PubMed ID: 8735976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
    Gronier B; Debonnel G
    Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCKA and CCKB receptor subtypes both mediate the effects of CCK-8 on myenteric neurons in the guinea-pig ileum.
    Schutte IW; Akkermans LM; Kroese AB
    J Auton Nerv Syst; 1997 Dec; 67(1-2):51-9. PubMed ID: 9470144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.
    Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E
    Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional expression of brain cholecystokinin and bombesin receptors in Xenopus oocytes.
    Moriarty TM; Gillo B; Sealfon S; Roberts JL; Blitzer RD; Landau EM
    Brain Res; 1988 Aug; 464(1):75-9. PubMed ID: 2902910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes.
    You ZB; Godukhin O; Goiny M; Nylander I; Ungerstedt U; Terenius L; Hökfelt T; Herrera-Marschitz M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro.
    Taniguchi H; Yazaki N; Endo T; Nagasaki M
    Eur J Pharmacol; 1996 May; 304(1-3):147-54. PubMed ID: 8813597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin activates CCKB-receptor-mediated Ca-signaling in hippocampal astrocytes.
    Müller W; Heinemann U; Berlin K
    J Neurophysiol; 1997 Oct; 78(4):1997-2001. PubMed ID: 9325368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A site-directed mutagenesis study on the conserved alanine residue in the distal third intracellular loops of cholecystokininB and neurotensin receptors.
    Wang HL
    Br J Pharmacol; 1997 May; 121(2):310-6. PubMed ID: 9154342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin excites neostriatal neurons in rats via CCKA or CCKB receptors.
    Davidowa H; Albrecht D; Gabriel HJ; Heublein S; Wetzel K
    Eur J Neurosci; 1995 Dec; 7(12):2364-9. PubMed ID: 8845940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dexloxiglumide and spiroglumide, two new CCK-receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo.
    Scarpignato C; Kisfalvi I; D'Amato M; Varga G
    Aliment Pharmacol Ther; 1996 Jun; 10(3):411-9. PubMed ID: 8791971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of CCKA receptor mediated pepsinogen secretion in porcine chief cells.
    Meyer G; Beinborn M; Sewing KF
    Pharmacology; 1996 Jul; 53(1):48-59. PubMed ID: 8875601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin-gated currents in neurons of the rat solitary complex in vitro.
    Branchereau P; Champagnat J; Denavit-Saubié M
    J Neurophysiol; 1993 Dec; 70(6):2584-95. PubMed ID: 7509860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
    O'Neill MF; Dourish CT; Iversen SD
    Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa.
    Heinemann A; Jocic M; Holzer-Petsche U; Pethö G; Peskar BM; Horwell DC; Holzer P
    Br J Pharmacol; 1995 Oct; 116(4):2274-8. PubMed ID: 8564259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCKB-receptor activation augments the long-term potentiation in guinea pig hippocampal slices.
    Yasui M; Kawasaki K
    Jpn J Pharmacol; 1995 Aug; 68(4):441-7. PubMed ID: 8531419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
    Hernandez-Gómez AM; Aguilar-Roblero R; Pérez de la Mora M
    Amino Acids; 2002; 23(1-3):283-90. PubMed ID: 12373548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
    Letari O; Mennuni L; Revel L; Colombo S; Makovec F
    Eur J Pharmacol; 1996 Jun; 306(1-3):325-33. PubMed ID: 8813647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.